GlaxoSmithKline To Pay $3 Billion To Settle Bribery, Fraud Allegations With US

submitted by Luis Kun

bulletinhealthcare.com - July 3, 2012

The announcement by the Justice Department of a settlement with drugmaker GlaxoSmithKline of bribery allegations generated heavy media coverage last night and this morning, including more than seven minutes of coverage on network newscasts.

        The CBS Evening News (7/2, story 6, 2:50, Pelley) reported, "The US government is calling it the biggest case of healthcare fraud in American history. The British drug maker GlaxoSmithKline is accused of withholding important safety information about the diabetes drug Avandia [rosiglitazone] and illegally promoting two other drugs for unapproved uses. GSK agreed to pay $3 billion in fines."

(READ COMPLETE ARTICLE)